Compared to existing treatments, the new drug offers a more favorable side effect profile and improved efficacy in certain cancers. Patients on this medication often experience a better quality of life due to fewer adverse effects. Additionally, its targeted action reduces the risk of developing resistance, a common issue with traditional therapies.